Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 7

Patient characteristics, treatment patterns, and health outcomes among COPD phenotypes

Authors Allen-Ramey FC, Gupta S, DiBonaventura MD

Received 30 June 2012

Accepted for publication 20 August 2012

Published 22 November 2012 Volume 2012:7 Pages 779—787

DOI https://dx.doi.org/10.2147/COPD.S35501

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Felicia C Allen-Ramey,1 Shaloo Gupta,2 Marco daCosta DiBonaventura3

1
Global Health Outcomes, Merck and Co, Inc, West Point, PA, 2Health Outcomes Practice, Kantar Health, Princeton, NJ, 3Health Outcomes Practice, Kantar Health, New York, NY, USA

Background: Recent literature has suggested that emphysema and chronic bronchitis, traditionally considered to be entities overlapping within chronic obstructive pulmonary disease (COPD), may be distinct disorders. Few studies have examined the differences in patient characteristics and health outcomes between these conditions. This study examined whether COPD phenotypes represent distinct patient populations, in a large nationally representative US sample.
Methods: Data were obtained from the 2010 US National Health and Wellness Survey (NHWS). NHWS respondents (n = 75,000) were categorized as a COPD phenotype based on their self-reported diagnosis of COPD only (n = 970), emphysema only (n = 399), or chronic bronchitis only (n = 2071). Phenotypes were compared on demographics, health characteristics, treatment patterns, health outcomes, work productivity, and resource use. Variables were compared using Chi-square and analysis of variance tests for categorical and continuous outcomes, respectively. Health outcomes were also examined using regression modeling, controlling for demographic and health characteristic covariates.
Results: Patients with chronic bronchitis were significantly younger (51.38 years versus 63.24 years for COPD versus 63.30 years for emphysema, P < 0.05) and more likely to be employed (46.98% versus 23.81% for COPD versus 28.33% for emphysema, P < 0.05). Relative to the other phenotypes, patients with chronic bronchitis were also significantly more likely to be female, nonwhite, and to exercise currently (all P < 0.05), and were significantly less likely to be a current or former smoker (P < 0.05). Controlling for demographic and health characteristics, patients self-identified as having COPD only reported significantly worse physical quality of life (adjusted mean 36.69) and health utilities (adjusted mean 0.65) and significantly more absenteeism (adjusted mean 7.08%), presenteeism (adjusted mean 30.73%), overall work impairment (adjusted mean 34.06%), and activity impairment (adjusted mean 46.59%) than the other phenotypes (all P < 0.05).
Conclusion: These results suggest considerable heterogeneity among different COPD phenotypes with respect to demographics, health characteristics, disease characteristics, treatment patterns, and health outcomes. Research aimed at understanding the differences in patient characteristics and disease presentation of these phenotypes could be used to guide treatment recommendations.

Keywords: chronic obstructive pulmonary disease, emphysema, chronic bronchitis, quality of life, work productivity, health care resource use

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Readers of this article also read:

Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease

Nishimura K, Nishimura T, Onishi K, Oga T, Hasegawa Y, Jones PW

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:155-162

Published Date: 5 February 2014

Suppression of IL-8 production from airway cells by tiotropium bromide in vitro

Suzaki I, Asano K, Shikama Y, Hamasaki T, Kanei A, Suzaki H

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:439-448

Published Date: 6 September 2011

Spirometric testing on World COPD Day

Tanja Grzetic-Romcevic, Boris Devcic, Silvana Sonc,

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:141-146

Published Date: 10 February 2011

Optimizing management of chronic obstructive pulmonary disease in the upcoming decade

Richard Russell, Antonio Anzueto, Idelle Weisman

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:47-61

Published Date: 10 January 2011